Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD/Hyper-CMAD plus dasatinib or Hyper-CVAD plus ponatinib

Authors

Yuya Sasaki MD, PhD
Hagop Kantarjian MD, The University of Texas MD Anderson Cancer Center
Nicholas J. Short MD
Farhad Ravandi MD
Marina Konopleva MD, PhD
Guillermo Garcia-Manero MD, The University of Texas MD Anderson Cancer Center
PAndrew Futreal PhD, The University of Texas MD Anderson Cancer Center
Feng Wang
Koichi Takahashi MD, PhD, The University of Texas MD Anderson Cancer Center
Elias Jabbour MD

Files

Description

Department of Leukemia Research

Department of Leukemia

Department of Genomic Medicine

Publication Date

4-27-2021

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston

Disciplines

Genetic Processes | Hematology | Oncology

Recommended Citation

Sasaki, Yuya MD, PhD; Kantarjian, Hagop MD; Short, Nicholas J. MD; Ravandi, Farhad MD; Konopleva, Marina MD, PhD; Garcia-Manero, Guillermo MD; Futreal, PAndrew PhD; Wang, Feng; Takahashi, Koichi MD, PhD; and Jabbour, Elias MD, "Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD/Hyper-CMAD plus dasatinib or Hyper-CVAD plus ponatinib" (2021). 2021 Education Week Posters. 5.
https://openworks.mdanderson.org/edwk21/5

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.